UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Cuts Stake in Encompass Health Corporation $EHC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its stake in shares of Encompass Health Corporation (NYSE:EHC) by 2.5% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 289,353 shares of the company’s stock after selling 7,451 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.29% of Encompass Health worth $29,248,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Transamerica Financial Advisors LLC purchased a new stake in shares of Encompass Health during the 2nd quarter worth approximately $29,000. Persistent Asset Partners Ltd bought a new position in Encompass Health during the second quarter valued at $36,000. Keating Financial Advisory Services Inc. purchased a new stake in Encompass Health in the second quarter worth $39,000. Assetmark Inc. raised its stake in shares of Encompass Health by 89.6% in the first quarter. Assetmark Inc. now owns 455 shares of the company’s stock valued at $44,000 after buying an additional 215 shares during the period. Finally, Caitong International Asset Management Co. Ltd lifted its position in shares of Encompass Health by 36,200.0% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock valued at $46,000 after buying an additional 362 shares during the last quarter. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Encompass Health

In other Encompass Health news, EVP John Darby sold 4,858 shares of Encompass Health stock in a transaction that occurred on Monday, August 31st. The shares were sold at an average price of $121.09, for a total transaction of $588,255.22. Following the completion of the sale, the executive vice president directly owned 75,041 shares in the company, valued at $9,086,714.69. The trade was a 6.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Mark Tarr sold 173,148 shares of the stock in a transaction on Monday, August 10th. The stock was sold at an average price of $125.47, for a total transaction of $21,724,879.56. Following the completion of the transaction, the chief executive officer directly owned 267,814 shares in the company, valued at $33,602,622.58. The trade was a 39.27% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 186,912 shares of company stock valued at $23,434,845. 1.80% of the stock is currently owned by company insiders.

Encompass Health Stock Up 1.3%

EHC opened at $122.79 on Friday. The firm has a market capitalization of $12.11 billion, a P/E ratio of 20.00, a price-to-earnings-growth ratio of 2.45 and a beta of 0.75. Encompass Health Corporation has a one year low of $92.77 and a one year high of $127.99. The company has a fifty day moving average price of $114.92 and a 200-day moving average price of $107.48. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.19 and a quick ratio of 1.19.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.48 by $0.07. The company had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.57 billion. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%.The firm’s quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter last year, the company earned $1.40 earnings per share. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. Equities research analysts expect that Encompass Health Corporation will post 6.08 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be given a $0.21 dividend. This represents a $0.84 annualized dividend and a dividend yield of 0.7%. This is a positive change from Encompass Health’s previous quarterly dividend of $0.19. The ex-dividend date is Thursday, October 1st. Encompass Health’s dividend payout ratio (DPR) is currently 12.38%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. TD Cowen lifted their price objective on Encompass Health from $125.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, August 10th. Leerink Partners set a $152.00 target price on shares of Encompass Health in a research report on Friday, May 22nd. Weiss Ratings raised shares of Encompass Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, August 12th. Barclays boosted their target price on shares of Encompass Health from $140.00 to $144.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Finally, Truist Financial raised their price target on Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Friday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $148.71.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.